Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 80255 BALTIMORE, MD
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$405,137
+$77,682 QoQ
Shares Held
50,579
+24.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 209 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. SPRY ranks #217 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in SPRY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $405,137 50,579
2026-03-31 $327,455 40,779
2025-12-31 $393,630 33,788
2025-09-30 $339,569 33,788
2025-06-30 $477,972 27,391
2025-03-31 $273,728 21,759
2024-12-31 $210,134 19,918
2024-09-30 $6,706,525 462,519
2024-06-30 $133,777 15,720
2023-06-30 $110,797 16,537
2023-03-31 $75,522 11,601
2022-09-30 $139,920 26,500
2022-06-30 $704,688 166,200
2022-03-31 $1,055,014 300,574
2021-12-31 $1,995,828 299,674